Xingwu Wang

3.6k total citations · 2 hit papers
35 papers, 2.4k citations indexed

About

Xingwu Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xingwu Wang has authored 35 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 15 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Xingwu Wang's work include MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (6 papers). Xingwu Wang is often cited by papers focused on MicroRNA in disease regulation (7 papers), Circular RNAs in diseases (7 papers) and Cancer-related molecular mechanisms research (6 papers). Xingwu Wang collaborates with scholars based in China, United States and Belgium. Xingwu Wang's co-authors include Mian Wu, Liyan Lv, Peng Jiang, Wenjing Du, Xiang Gao, Xiaolu Yang, Anthony Mancuso, Ling Wei, Ming Yang and Nasha Zhang and has published in prestigious journals such as Nature Communications, Nature Cell Biology and Scientific Reports.

In The Last Decade

Xingwu Wang

35 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase

2011 619 citations Peng Jiang, Wenjing Du et al. Nature Cell Biology profile →
Noncoding RNAs in gastric cancer: implications for drug resistance

2020 351 citations Ling Wei, Nasha Zhang et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xingwu Wang China	19	1.6k	1.4k	459	210	162	35	2.4k
Xiaohu Tang United States	28	1.8k 1.1×	1.1k 0.8×	516 1.1×	281 1.3×	143 0.9×	40	2.4k
Yekaterina Y. Zaytseva United States	24	1.4k 0.9×	1.0k 0.8×	368 0.8×	177 0.8×	213 1.3×	49	2.1k
Rafael Malagoli Rocha Brazil	18	1.5k 0.9×	1.0k 0.7×	639 1.4×	244 1.2×	161 1.0×	49	2.2k
Wenjing Du China	20	1.8k 1.1×	1.3k 0.9×	623 1.4×	190 0.9×	207 1.3×	36	2.7k
Yufeng Wang China	28	2.0k 1.2×	1.7k 1.2×	337 0.7×	214 1.0×	183 1.1×	42	2.5k
Chaoqun Wang China	24	1.7k 1.0×	978 0.7×	357 0.8×	295 1.4×	134 0.8×	86	2.3k
Mingxia Yan China	20	1.9k 1.1×	1.4k 1.0×	945 2.1×	180 0.9×	141 0.9×	37	2.7k
Vilma Maldonado Mexico	24	1.2k 0.7×	725 0.5×	497 1.1×	213 1.0×	187 1.2×	88	1.9k
Paolo Gandellini Italy	31	2.2k 1.4×	1.7k 1.3×	527 1.1×	358 1.7×	126 0.8×	62	2.9k
Qingguang Liu China	32	1.9k 1.2×	1.4k 1.0×	466 1.0×	196 0.9×	243 1.5×	67	2.7k

Countries citing papers authored by Xingwu Wang

Since Specialization

Citations

This map shows the geographic impact of Xingwu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingwu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingwu Wang more than expected).

Fields of papers citing papers by Xingwu Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingwu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingwu Wang. The network helps show where Xingwu Wang may publish in the future.

Co-authorship network of co-authors of Xingwu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xingwu Wang. A scholar is included among the top collaborators of Xingwu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingwu Wang. Xingwu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Yanxi, Juan Zou, Huimin Kong, et al.. (2025). Protein kinase A regulates ferroptosis by controlling GPX4 m6A modification through phosphorylation of ALKBH5. Cell Death and Differentiation. 32(6). 1058–1070. 4 indexed citations

Huang, Minyi, Juan Zou, Yanxi Sun, et al.. (2025). p14ARF interacts with γ-H2AX and is involved in the DNA damage response. Biochemical and Biophysical Research Communications. 765. 151847–151847. 1 indexed citations

Wu, Peng, Dongyu Li, Chaoqi Zhang, et al.. (2024). A unique circulating microRNA pairs signature serves as a superior tool for early diagnosis of pan-cancer. Cancer Letters. 588. 216655–216655. 7 indexed citations

Yu, Zhiyong, Dawei Chen, Vivek Verma, et al.. (2022). Pivotal roles of tumor‐draining lymph nodes in the abscopal effects from combined immunotherapy and radiotherapy. Cancer Communications. 42(10). 971–986. 30 indexed citations

Qian, Xin, Qinghong Ji, Ying Zhang, et al.. (2022). Aberrant ROS Served as an Acquired Vulnerability of Cisplatin‐Resistant Lung Cancer. Oxidative Medicine and Cellular Longevity. 2022(1). 1112987–1112987. 6 indexed citations

Wei, Ling, Xingwu Wang, Liyan Lv, et al.. (2019). The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma. Molecular Cancer. 18(1). 147–147. 246 indexed citations

Wei, Ling, Xingwu Wang, Liyan Lv, et al.. (2019). The emerging role of noncoding RNAs in colorectal cancer chemoresistance. Cellular Oncology. 42(6). 757–768. 72 indexed citations

Wang, Xiangyu, Jim Jinn‐Chyuan Sheu, Ming-Tsung Lai, et al.. (2018). RSF-1 overexpression determines cancer progression and drug resistance in cervical cancer. Biomedicine. 8(1). 4–4. 41 indexed citations

Chang, Ming‐Hui, Xingguo Song, Xinran Geng, et al.. (2018). Temozolomide-Perillyl alcohol conjugate impairs Mitophagy flux by inducing lysosomal dysfunction in non-small cell lung Cancer cells and sensitizes them to irradiation. Journal of Experimental & Clinical Cancer Research. 37(1). 250–250. 19 indexed citations

10.

Song, Xingguo, Li Xie, Xingwu Wang, et al.. (2016). Temozolomide-perillyl alcohol conjugate induced reactive oxygen species accumulation contributes to its cytotoxicity against non-small cell lung cancer. Scientific Reports. 6(1). 22762–22762. 22 indexed citations

11.

Stapor, Peter C., Xingwu Wang, Jermaine Goveia, Stijn Moens, & Peter Carmeliet. (2014). Angiogenesis revisited – role and therapeutic potential of targeting endothelial metabolism. Journal of Cell Science. 127(Pt 20). 4331–41. 75 indexed citations

12.

Fang, Ming, et al.. (2013). [Early outcome of using Zero-profile implant system in treatment of cervical spondylosis].. PubMed. 27(10). 1206–9. 4 indexed citations

13.

Schoors, Sandra, Anna Rita Cantelmo, Μαρία Γεωργιάδου, et al.. (2013). Incomplete and transitory decrease of glycolysis. Cell Cycle. 13(1). 16–22. 45 indexed citations

14.

Wang, Xingwu, Meng Zha, Peng Jiang, et al.. (2013). Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase. Nature Communications. 4(1). 1551–1551. 44 indexed citations

15.

Hu, Xudong, Ligang Xing, Yang Jiao, et al.. (2012). BTG2 Overexpression Increases the Radiosensitivity of Breast Cancer Cells In Vitro and In Vivo. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 20(10). 457–465. 18 indexed citations

16.

Jiang, Peng, Wenjing Du, Xingwu Wang, et al.. (2011). p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nature Cell Biology. 13(3). 310–316. 619 indexed citations breakdown →

17.

Liu, Naifu, Xingwu Wang, & Xiugui Sheng. (2010). The clinicopathological characteristics of ‘triple-negative’ epithelial ovarian cancer. Journal of Clinical Pathology. 63(3). 240–243. 16 indexed citations

18.

Song, Bao, Chuanxi Wang, Jie Liu, et al.. (2010). MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. Journal of Experimental & Clinical Cancer Research. 29(1). 29–29. 214 indexed citations

19.

Liu, Naifu, Xingwu Wang, & Xiugui Sheng. (2010). ‘Triple negative’ epithelial ovarian cancer and pathologic markers for prognosis. Current Opinion in Obstetrics & Gynecology. 23(1). 19–23. 5 indexed citations

20.

Wang, Xingwu, Michael A. Sirover, & Louise E. Anderson. (1999). Pea Chloroplast Glyceraldehyde-3-Phosphate Dehydrogenase Has Uracil Glycosylase Activity. Archives of Biochemistry and Biophysics. 367(2). 348–353. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact